Related references
Note: Only part of the references are listed.Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells
Jihene Klibi et al.
BLOOD (2009)
Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: Bases for improved immunotherapy
Debora Martorelli et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma
Dewi K. Paramita et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function
Jianmin Zuo et al.
JOURNAL OF VIROLOGY (2008)
Contribution of the Epstein-Barr virus to the molecular pathogenesis of Hodgkin lymphoma
G. Kapatai et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma
Dewi K. Paramita et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation
Emmanuel J. Wiertz et al.
JOURNAL OF VIROLOGY (2007)
Epstein-Barr virus: Evasive maneuvers in the development of PTLD
Andrew L. Snow et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
Cecile Keryer-Bibens et al.
BMC CANCER (2006)
Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray
Michele Bernasconi et al.
VIROLOGY JOURNAL (2006)
Single-assay combination of Epstein-Barr virus (EBV) EBNA1-and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: Options for field screening
J Fachiroh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes
P Comoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces
P Timmerman et al.
CHEMBIOCHEM (2005)
Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression
E Seto et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia
H Karray et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Expression and analysis of the Epstein-Barr virus BARF1-encoded protein from a tetracycline-regulatable adenovirus system
M de Turenne-Tessier et al.
VIRUS RESEARCH (2005)
Screening for family members of patients with nasopharyngeal carcinoma
WT Ng et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas
Abdelmajid Khabir et al.
VIROLOGY JOURNAL (2005)
EBV-positive gastric adenocarcinomas: A distinct clinicopathologic entity with a low frequency of lymph node involvement
J van Beek et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: A comparison of Indonesian, Chinese, and European subjects
J Fachiroh et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma
P Comoli et al.
ANNALS OF ONCOLOGY (2004)
Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma
N Heussinger et al.
JOURNAL OF PATHOLOGY (2004)
Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases
M Swanson-Mungerson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Regulatory T cells secreting IL-10 dominate the immune response to EBV latent membrane protein 1
NA Marshall et al.
JOURNAL OF IMMUNOLOGY (2003)
Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease
P Meij et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum
WM Cheng et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Production monitoring and purification of EBV encoded latent membrane protein 1 expressed and secreted by recombinant baculovirus infected insect cells
P Meij et al.
JOURNAL OF VIROLOGICAL METHODS (2000)
Bioreactor-scale production and one-step purification of Epstein-Barr nuclear antigen 1 expressed in baculovirus-infected insect cells
P Meij et al.
PROTEIN EXPRESSION AND PURIFICATION (2000)
Direct immunosuppressive effects of EBV-encoded latent membrane protein 1
DF Dukers et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
